Live Analyst Rating Changes 1505 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Matthew Heimermann
Citi
Matthew Heimermann
Wall Street Analyst
★★★★☆
#462
on 13Foresight · ranked by our own returns
67%
Success Rate
+2.5%
Average Return
12 of 18 calls profitable · -1.5% vs benchmark
📈 Across the calls we could measure, roughly 67% of Matthew Heimermann's ratings turned a profit when each position was held for 1 year — averaging +2.5% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

37 Buy 40 Hold 0 Sell
Matthew's Stock Coverage 18 ratings · 2026-06-18
Company Date Position Consensus Price Target 1-Yr Return
RNR
Renaissancere Holdings
Jun 10, 2026 BUY Buy
-4.8% avg upside
23 analysts
$345.00
13.76% Upside
+0.7%
AON
Aon
May 27, 2026 BUY Buy
+9.4% avg upside
29 analysts
$420.00
28.53% Upside
+4.0%
PS
Pershing Square Inc.
May 26, 2026 BUY Buy
+23.1% avg upside
22 analysts
$50.00
44.59% Upside
-6.9%
EG
Everest Group
May 12, 2026 HOLD Buy
+11.4% avg upside
21 analysts
$395.00
16.97% Upside
-3.1%
AJG
Arthur J Gallagher & Co
May 06, 2026 BUY Strong Buy
+21.4% avg upside
30 analysts
$250.00
15.64% Upside
+11.4%
BRO
Brown & Brown
May 06, 2026 BUY Buy
+26.9% avg upside
25 analysts
$70.00
18.61% Upside
+4.7%
MRSH
Marsh & McLennan Companies
May 06, 2026 BUY Buy
+17.7% avg upside
29 analysts
$200.00
21.73% Upside
·
WTW
Willis Towers Watson
May 06, 2026 BUY Strong Buy
+27.6% avg upside
28 analysts
$300.00
15.45% Upside
+4.0%
RYAN
Ryan Specialty Group
May 06, 2026 BUY Buy
+34.6% avg upside
24 analysts
$50.00
41.79% Upside
+20.8%
AIG
American International Group
May 04, 2026 HOLD Buy
+12.3% avg upside
32 analysts
$88.00
17.63% Upside
-2.4%
ALL
Allstate
May 01, 2026 HOLD Buy
-9.2% avg upside
34 analysts
$226.00
1.92% Upside
+1.4%
ASIC
Ategrity Specialty Holdings LLC
Feb 26, 2026 HOLD Strong Buy
+26.7% avg upside
5 analysts
$27.00
28.58% Upside
·
HG
Hamilton Insurance Group, Ltd. Class B
Feb 24, 2026 HOLD Strong Buy
-0.1% avg upside
9 analysts
$33.00
3.54% Upside
+11.7%
ACGL
Arch Capital Group
Feb 13, 2026 BUY Buy
+15.2% avg upside
25 analysts
$120.00
29.84% Upside
-6.1%
CB
Chubb
Feb 09, 2026 BUY Buy
-6.8% avg upside
32 analysts
$385.00
17.46% Upside
+0.3%
HIG
Hartford Insurance
Feb 04, 2026 HOLD Buy
-0.2% avg upside
31 analysts
$143.00
10.41% Upside
-7.1%
PGR
Progressive
Feb 03, 2026 BUY Buy
+9.4% avg upside
29 analysts
$261.00
27.59% Upside
+2.0%
TRV
Travelers Companies
Jan 27, 2026 HOLD Hold
-6.1% avg upside
32 analysts
$315.00
2.96% Upside
+9.9%
🔒 13 more ratings — with price targets, crowd consensus and our measured returns.
Free account unlocks every analyst's full coverage table.
Matthew Heimermann — Frequently Asked Questions
How accurate are Matthew Heimermann's stock ratings?
Based on the calls 13Foresight could measure, about 67% of Matthew's ratings were profitable over a one-year hold, with an average return of +2.5% per rating, or -1.5% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Matthew ranked on 13Foresight?
Matthew Heimermann is currently ranked #462 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Matthew cover?
Matthew most recently has ratings on RNR, AON, PS, EG, AJG, BRO, MRSH, WTW, RYAN, AIG, ALL, ASIC and 6 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.